Taxpayers paid for their care at the VA—and for Medicare Advantage coverage that many didn’t use. ‘I don’t think I’ve used my ...

Selecting the right 2025 Medicare Part D prescription drug plan or private insurer’s Medicare Advantage plan during Open ...

CVS Health Corp. is talking to investors about possibly selling bonds and at the same time said it’s buying back as much as ...

Columnist Teri Sforza writes that the countersuit says the insurer ‘cynically and unscientifically’ denied payment, which may ...

Negotiations are expected to continue. "The deadline is past, but the door hasn't been closed," said Dr. Michael Schooff, CHI ...

The Medicare Advantage program is expected to cost taxpayers and beneficiaries more than $500 billion this year.

Sachin H. Jain’s annual healthcare industry predictions covers a wide range of topics including private equity, the incoming ...

Faced with challenges such as falling prescription reimbursement levels, allegedly persistent theft and changing consumer ...

Analysts have set 12-month price targets for CVS Health, revealing an average target of $68.83, a high estimate of $85.00, ...

Latham Thomas's Mama Glow is fighting for birth equity and, in the process, supporting thousands of new entrepreneurs.

CVS Health Corporation ("CVS Health" or the "Company," NYSE: CVS) announced today that it has commenced cash tender offers (the "Tender Offers," and each a "Tender Offer") for (1) any and all of its 4 ...